The results showed that patients with high APOC2 expression had markedly shorter overall survival (OS) and disease-free survival (DFS) compared with those with low expression, suggesting that elevated APOC2 expression may be associated with poor prognosis in ccRCC (Figure 1C,D). Here, APOC2 is linked to nonpapillary renal cell carcinoma.